美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

Fentanyl Citrate, Bupivacaine HCl

HUMAN COMPOUNDED DRUG

61141-4837

Medi-Fare Drug

2024-2

BUPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1.25 mg/1 mL; 2 ug/1 mL

61141-4837-1

Neostigmine Methylsulfate

HUMAN COMPOUNDED DRUG

61141-1372

Medi-Fare Drug

2024-2

NEOSTIGMINE METHYLSULFATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

61141-1372-5

Rocuronium Bromide

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL

73177-159-02

Furosemide

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL

73177-157-03

Furosemide

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL

73177-157-01

Methadone HCl

HUMAN COMPOUNDED DRUG

73177-161

STAQ Pharma Inc

2024-2

METHADONE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL

73177-161-43

Atropine Sulfate

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.4 mg/1 mL

73177-122-01

Phenylephrine

HUMAN COMPOUNDED DRUG

73177-115

STAQ Pharma Inc

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

80 ug/1 mL

73177-115-25

Phenylephrine

HUMAN COMPOUNDED DRUG

73177-115

STAQ Pharma Inc

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

80 ug/1 mL

73177-115-03

Sodium Chloride

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

9 mg/1 mL

73177-169-28

Sodium Chloride

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

9 mg/1 mL

73177-169-26

Cyclopentolate Hydrochloride, Tropicamide, Phenylephrine Hydrochloride

HUMAN COMPOUNDED DRUG

71449-092

Denver Solutions, LLC dba Leiters Health

2024-2

CYCLOPENTOLATE HYDROCHLORIDE; TROPICAMIDE; PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL; 10 mg/1 mL; 25 mg/1 mL

71449-092-46

Bupivacaine, Dexamethasone, Epinephrine

HUMAN COMPOUNDED DRUG

71449-134

Denver Solutions, LLC dba Leiters Health

2024-2

EPINEPHRINE; BUPIVACAINE HYDROCHLORIDE; DEXAMETHASONE SODIUM PHOSPHATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

5 ug/1 mL; 3.75 mg/1 mL; .1 mg/1 mL

71449-134-24

Ephedrine Sulfate

HUMAN COMPOUNDED DRUG

71449-106

Denver Solutions, LLC dba Leiters Health

2024-2

EPHEDRINE SULFATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

5 mg/1 mL

71449-106-15

Ephedrine Sulfate

HUMAN COMPOUNDED DRUG

71449-106

Denver Solutions, LLC dba Leiters Health

2024-2

EPHEDRINE SULFATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

5 mg/1 mL

71449-106-11

Neostigmine Methylsulfate

HUMAN COMPOUNDED DRUG

71449-125

Denver Solutions, LLC dba Leiters Health

2024-2

NEOSTIGMINE METHYLSULFATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

71449-125-11

Midazolam Hydrochloride

HUMAN COMPOUNDED DRUG

71449-130

Denver Solutions, LLC dba Leiters Health

2024-2

MIDAZOLAM HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

5 mg/1 mL

71449-130-32

Trophamine 3% / Dextrose 5% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag

HUMAN COMPOUNDED DRUG

72196-0427

Central Admixture Pharmacy Services, Inc.

2024-2

VALINE; CALCIUM GLUCONATE MONOHYDRATE; HEPARIN SODIUM; GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.585 g/250 mL; 2.33 meq/250 mL; 125 U/250 mL; .375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 12.5 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL

72196-0427-1

Epinephrine 4mg added to D5W

HUMAN COMPOUNDED DRUG

72196-7018

Central Admixture Pharmacy Services, Inc.

2024-2

EPINEPHRINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

4 mg/250 mL

72196-7018-1

Epinephrine 8mg added to D5W

HUMAN COMPOUNDED DRUG

72196-7019

Central Admixture Pharmacy Services, Inc.

2024-2

EPINEPHRINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

8 mg/250 mL

72196-7019-1

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：